AI-generated summary
The authors report a systematic review and network meta-analysis of 44 randomized controlled trials, 24 of which were included in the network, comparing treatments for pain in burning mouth syndrome. Clonazepam probably reduces pain compared with placebo with moderate certainty, while photobiomodulation therapy and pregabalin reached the minimal important difference with low or very low certainty. The authors note that most other treatments had low or very low certainty of evidence.
- Studies included
- 44
- Who or what was studied
- Patients with burning mouth syndrome enrolled in randomized controlled trials
- Limits stated in the abstract
- Most treatments had low or very low certainty of evidence, mainly due to imprecision, indirectness, and intransitivity, and the authors call for more placebo-controlled trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Meta-analysis, Photobiomodulation therapy, Photobiomodulation, Systematic review, Primary outcome, Risk of bias, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.